Future studies are needed to clarify tissue-specific G6PD contribution to arterial stiffening in diabetic subjects, and its possible role for the development of new therapeutic agents able to reduce the cardiovascular burden of diabetes mellitus. Here, G6PD is linked to diabetes mellitus.